TotalMarketCap

Aptevo Therapeutics

APVONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.305 M

$1.24 -9.49%

Close of 6 Nov 2026

As of 6 Nov 2026, Aptevo Therapeutics (APVO) has a market capitalization of $3.30M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$26.0M

Loss-making

Shares outstanding

1,801,970

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #465Medicus PharmaMDCX$3.45M
  2. #466Traws PharmaTRAW$3.38M
  3. #467Aptevo TherapeuticsAPVO$3.30M
  4. #468OnconetixONCO$3.27M
  5. #46960 Degrees PharmaceuticalsSXTP$3.18M

What if Aptevo Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$10,594,684

Per share 8,544,100× higher

Bitcoin $1.53T

$573,259.88

Per share 462,306× higher

Apple $5.02T

$1,881,959

Per share 1,517,709× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Aptevo Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.